Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Damiano de Felice to speak at SRI 29

On 1 November, Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will speak at the SRI 29 Conference in Colorado Springs, USA.

Date

01 November 2018

Damiano will join a panel discussion titled ‘Strengthening the ‘’S’’ in ESG’ where he will speak about the framework for analysis and methodology used for the 2018 Access to Medicine Index and the Access to Medicine Foundation’s investor engagement programme. The panel discussion is part of the ‘ESG integration’ workstream of the conference, which brings experts together to share their frameworks for the application of environmental, social, and governance (ESG) metrics in their investment analysis – providing important insights and data for asset managers, advisors, and corporate sustainability professionals.

Seventy-six institutional investors, collectively managing assets in excess of $10 trillion, have already committed to using the Access to Medicine Index in their investment analyses and engagements with companies, by signing the Index investor statement. Damiano will share the importance of coordinating the work of the Access to Medicine Foundation with other standard setting organisations, such as the Sustainability Accounting Standards Board (SASB) – who refer to the indicators and scopes of the Access to Medicine Index in the Exposure Draft of the SASB Standard for the Pharmaceutical Industry.

The SRI Conference is an annual gathering of sustainability professionals, financial advisors, investment managers, members of mission-driven organisations, researchers, and private- and public- sector professionals who share a common goal of deploying capital as a change agent.

Later this month, the Access to Medicine Foundation will be launching the 2018 Access to Medicine Index with a series of events for investors taking place in London (22 November), New York (7 December) and Tokyo (11 December). Keep an eye on our website for more details.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved